Paper
0
Five-Year Analysis of the POLARIX Study: Prolonged Follow-up Confirms Positive Impact of Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (Pola-R-CHP) on Outcomes
Authors
Gilles Salles,Franck Morschhauser
Laurie Sehn,Alex Herrera,Jonathan Friedberg,Marek Trněný,Georg Lenz,Jeff Sharman,Charles Herbaux,John Burke,Matthew Matasar,Graham Collins,Yuqin Song,Antonio Pinto,Shinya Rai,Koji Izutsu,Calvin Lee,Saibah Chohan,Matthew Sugidono,Yanwen Jiang,Connie Batlevi,Mark Yan,Jamie Hirata,Hervé Tilly
+22 authors
,Christopher FlowersJournal
Published
Nov 5, 2024
Show more
Save
Tip0
TipSave
Abstract
Paper PDF
This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.